Silence Therapeutics plc

SLN · NASDAQ
Analyze with AI
$6.46+$0.14 (+2.22%)
At close:Dec 15, 2025, 6:08 PM UTC
$6.50+$0.0414 (+0.64%)
After hours:Dec 15, 2025, 6:09 PM UTC
P/E TTM-1.75
P/B TTM-1.35
P/S TTM12.3
Dividend Yield0%
EPS-$1.35
Beta1.343
Valuation
PEG Ratio0.06
FCF Yield-22.91%
EV / EBITDA-3.19
More On Valuation »
Quality
ROIC-69.59%
Gross Margin92.87%
Cash Conv. Ratio-3.05
More On Quality »
Growth
Revenue 3Y CAGR25.94%
FCF Growth-72.23%
More On Growth »
Safety
Net Debt / EBITDA1.18
Interest Coverage6.49
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-3,102.02
More On Efficiency »

Silence Therapeutics plc (SLN) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Silence Therapeutics plc (SLN) stock price today?

As of Dec 15, 2025, 6:08 PM UTC, Silence Therapeutics plc (SLN) stock is trading at $6.46. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date SLN stock quotes for informed trading decisions.

What is Silence Therapeutics plc's market capitalization?

Silence Therapeutics plc (SLN) has a market capitalization of approximately $305.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Silence Therapeutics plc's size relative to other companies in the USD market. The market cap figure updates automatically as the SLN stock price changes.

What is the 52-week range for Silence Therapeutics plc stock?

Silence Therapeutics plc (SLN) stock has traded in a 52-week range of $1.97 — $8.08. The 52-week range shows the highest and lowest prices at which SLN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Silence Therapeutics plc stock price to this range provides context for recent price action.

How much trading volume does Silence Therapeutics plc stock have?

Silence Therapeutics plc (SLN) stock recently traded approximately 41.1K shares. Trading volume indicates market liquidity and investor interest in SLN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Silence Therapeutics plc stock.

Does Silence Therapeutics plc pay dividends to shareholders?

Yes, Silence Therapeutics plc (SLN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Silence Therapeutics plc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Silence Therapeutics plc's intraday price range?

Today, Silence Therapeutics plc (SLN) stock has traded in a range of $6.15 — $6.52. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring SLN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Silence Therapeutics plc stock data?

AlphaPilot sources real-time SLN stock quotes, fundamental financial data, and historical price charts for Silence Therapeutics plc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Silence Therapeutics plc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of SLN stock performance.